Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.
2011; National Institutes of Health; Volume: 34; Issue: 2 Linguagem: Inglês
Autores
Andrea Antinori, S Marcotullio, Adriana Ammassari, Massimo Andreoni, Gioacchino Angarano, G. Carosi, Paola Cinque, Antonella d’Arminio Monforte, Di Perri G, Barbara Ensoli, E. Ferrazzi, Massimo Galli, Claudio Maria Mastroianni, Alberto Matteelli, Francesco Mazzotta, Mauro Moroni, Giorgio Palù, Massimo Puoti, Vincenzo Puro, Giuliano Rizzardini, Evangelista Sagnelli, Fredy Suter, Stefano Vella, Adriano Lazzarin,
Tópico(s)Pneumocystis jirovecii pneumonia detection and treatment
ResumoThe Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.
Referência(s)